What Is KPV Used For in Research?
KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH) investigated primarily for its targeted anti-inflammatory and epithelial barrier-modulating properties. In preclinical models, researchers utilize KPV to evaluate nuclear factor kappa B (NF-κB) signaling inhibition, mucosal barrier restoration, and localized cytokine suppression without inducing systemic melanogenic activity.
Quick answer
KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH) investigated primarily for its targeted anti-inflammatory and epithelial barrier-modulating properties. In preclinical models, researchers utilize KPV to evaluate nuclear factor kappa B (NF-κB) signaling inhibition, mucosal barrier restoration, and localized cytokine suppression without inducing systemic melanogenic activity.
Key takeaways
- In laboratory research settings, [KPV](/research-peptides/kpv) is primarily used as a targeted molecular tool to study localized anti-inflammatory signaling pathways, particularly within epithelial and mucosal tissue models.
- [KPV](/research-peptides/kpv) is a tripeptide composed of the amino acid sequence Lysine-Proline-Valine.
- In cell-based models, researchers utilize [KPV](/research-peptides/kpv) to examine the fundamental mechanisms governing nuclear factor kappa B (NF-κB) activation.
- The most extensive body of [KPV](/research-peptides/kpv) research centers on rodent models of inflammatory bowel disease (IBD), specifically dextran sulfate sodium (DSS)-induced and trinitrobenzenesulfonic acid (TNBS)-induced colitis.
Direct Answer: Primary Preclinical Applications of KPV
In laboratory research settings, KPV is primarily used as a targeted molecular tool to study localized anti-inflammatory signaling pathways, particularly within epithelial and mucosal tissue models. Derived from the C-terminal region of α-MSH, the tripeptide maintains key immunomodulatory functions while lacking the melanogenic affinity associated with larger melanocortin peptides. Researchers frequently integrate KPV 10mg into experimental designs aimed at dissecting inflammatory cascades.
Preclinical investigations concentrate heavily on gastrointestinal models, where KPV is evaluated for its ability to preserve tight junction architecture and downregulate pro-inflammatory gene expression. Additionally, researchers explore its utility in dermal wound-healing assays, corneal epithelial damage models, and comparative studies alongside broader research peptides targeting cellular homeostasis.
Molecular Structure and Derivation of Lysine-Proline-Valine
KPV is a tripeptide composed of the amino acid sequence Lysine-Proline-Valine. It corresponds to residues 11–13 of the native neuroimmunomodulatory hormone α-MSH. While native α-MSH exerts systemic endocrine effects by activating multiple melanocortin receptors (MC1R through MC5R), the truncated tripeptide exhibits a distinct pharmacodynamic profile centered on localized cellular transport and nuclear interaction.
In vitro structural analyses reveal that KPV can enter target cells through active peptide transporters, such as PepT1 (SLC15A1), which is prominently expressed on intestinal epithelial cells and macrophages. Once inside the intracellular compartment, KPV interacts directly with inflammatory transcription machinery. The absence of the N-terminal sequence present in full-length α-MSH eliminates melanocortin receptor-mediated pigment stimulation, making KPV an ideal candidate for isolating anti-inflammatory pathways from pigmentary signaling.
In Vitro Research Models: Cellular Signaling and NF-κB Suppression
In cell-based models, researchers utilize KPV to examine the fundamental mechanisms governing nuclear factor kappa B (NF-κB) activation. NF-κB is a primary transcriptional driver of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). In vitro assays using Caco-2 intestinal cell lines or RAW 264.7 macrophages demonstrate that KPV exposure inhibits the translocation of the NF-κB p65 subunit into the nucleus following lipopolysaccharide (LPS) stimulation.
Furthermore, cellular assays measure how KPV modulates intracellular oxidative stress. Exposure to oxidative challenges typically leads to a breakdown in membrane potential and elevated reactive oxygen species (ROS). Preclinical assays indicate that KPV administration preserves cellular viability by blunting ROS generation and suppressing inducible nitric oxide synthase (iNOS) expression. Investigating these molecular pathways provides valuable data regarding intracellular signaling cascades in response to acute inflammatory stimuli.
In Vivo Rodent Models: Intestinal Barrier Integrity and Colitis Assays
The most extensive body of KPV research centers on rodent models of inflammatory bowel disease (IBD), specifically dextran sulfate sodium (DSS)-induced and trinitrobenzenesulfonic acid (TNBS)-induced colitis. In these experimental frameworks, animal models display mucosal erosion, neutrophil infiltration, elevated cytokine profiles, and severe degradation of tight junction proteins. Researchers administer KPV orally, parenterally, or via targeted nanoparticulate delivery systems to quantify mucosal preservation and histological recovery.
Primary endpoints evaluated in rodent colitis assays include histological scoring of mucosal damage, measurement of myeloperoxidase (MPO) activity as a marker for neutrophil infiltration, and quantification of tight junction proteins such as Zonula Occludens-1 (ZO-1), Occludin, and Claudin family members. Preclinical studies suggest that KPV treatment significantly attenuates histological inflammation scores, reduces MPO levels, and restores membrane-bound tight junction expression, thereby reducing intestinal permeability.
Dermatological, Cutaneous, and Ocular Preclinical Assays
Beyond gastrointestinal research, KPV is widely evaluated in cutaneous and ocular inflammation models. In vitro human keratinocyte (HaCaT) assays and murine contact hypersensitivity models demonstrate that KPV application suppresses contact allergen-induced swelling and reduces the production of pro-inflammatory chemokines such as IL-8 and MCP-1. Because skin inflammation often involves microbial colonization, researchers also study KPV's intrinsic antimicrobial properties against pathogens like *Staphylococcus aureus* and *Candida albicans*.
In ocular models, corneal epithelial damage assays assess KPV's role in promoting re-epithelialization following chemical or mechanical injury. In vitro corneal cell cultures exposed to KPV display accelerated cell migration across scratch-wound gaps without excessive fibroblastic scar formation. These findings highlight KPV as a versatile compound for investigating multi-tissue epithelial recovery mechanisms.
Comparative Analysis: KPV vs. Other Inflammatory and Mucosal Peptides
When designing protocols for inflammatory or barrier-repair assays, investigators frequently evaluate KPV alongside related signaling peptides. Understanding the distinct operational characteristics of these compounds allows researchers to select the optimal molecular tool for specific model systems.
In gastrointestinal and tissue repair models, KPV is frequently compared to BPC-157, Larazotide Acetate, and parent compound Alpha-MSH. While BPC-157 acts largely through angiogenic (VEGFR2) and focal adhesion signaling pathways, and Larazotide acts specifically as a tight junction receptor antagonist to prevent zonulin-induced pore opening, KPV directly regulates intracellular NF-κB nuclear translocation and PepT1-mediated transport. Native α-MSH provides broad neuroimmunomodulatory effects but engages melanocortin receptors across multiple organ systems. KPV’s specific target profile offers localized anti-inflammatory action without melanocortin-mediated endocrine interference.
Key Quantitative Endpoints and Analytical Metrics in KPV Research
To evaluate KPV efficacy in laboratory assays, researchers rely on a structured battery of quantitative analytical metrics across molecular, cellular, and tissue-level endpoints:
1. Transepithelial Electrical Resistance (TEER): Measured in cell culture inserts (e.g., Caco-2 monolayers) to quantify mucosal barrier tightness and ion permeability prior to and following inflammatory challenge. 2. NF-κB p65 Nuclear Translocation: Assessed via immunofluorescence microscopy or Western blotting of nuclear fractions to measure intracellular transcriptional activation. 3. Inflammatory Cytokine Gene Expression: Quantified via quantitative reverse transcription PCR (RT-qPCR) for IL-1β, IL-6, TNF-α, and IL-8 transcripts. 4. Myeloperoxidase (MPO) Enzymatic Activity: Spectrophotometric quantification of neutrophil accumulation within tissue homogenates. 5. Tight Junction Protein Expression: Western blot and immunohistochemical analysis measuring ZO-1 and Occludin protein densities at the intercellular border.
Reconstitution, Handling, and Storage Protocols for Laboratory Use
Achieving reproducible experimental results requires precise handling and reconstitution protocols. Reagents should be prepared in a sterile environment using proper aseptic technique. To calculate exact molar concentrations and solvent volumes for specific assay setups, investigators should consult our interactive reconstitution calculator.
Lyophilized KPV should be stored at -20°C or -80°C for long-term stability. For reconstitution, sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) is recommended depending on the requirements of the downstream cell culture or animal model setup. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade peptide chain integrity. Reconstituted aqueous solutions stored at 4°C should be utilized within recommended research windows to ensure consistent bioactivity.
Quality Standards: Purity Verification, Endotoxin Limits, and COAs
Experimental integrity depends entirely on the chemical purity and quality of the research peptides employed. Impurities such as residual trifluoroacetate (TFA) salts, truncated peptide fragments, or bacterial endotoxins can confound cell culture viability assays and produce false-positive or false-negative inflammatory signaling data.
At PX1 Research, every production lot undergoes rigorous analytical testing at an ISO 17025-accredited laboratory. Chemical identity and purity are verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), ensuring minimum purities of 99%. Crucially for inflammatory research, every lot is subjected to Chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm low endotoxin levels. Researchers can review lot-specific analytical data directly by accessing our dedicated COA repository.
Sourcing High-Purity KPV for High-Throughput Research
Securing consistent, highly characterized reagents is critical for high-throughput screening and long-term research projects. Substandard peptide quality introduces unquantifiable variables that jeopardize experimental reproducibility and waste valuable laboratory resources. PX1 Research supplies USA-manufactured research peptides synthesized in GMP-compliant facilities to meet the stringent demands of modern academic and private scientific institutions.
Facilities ordering reagents in bulk or establishing recurring research protocols can register for institutional purchasing options through our wholesale program. Orders are processed with same-day dispatch (Monday through Friday) from our CA and AZ logistics hubs, ensuring rapid supply chain turnaround for time-sensitive experiments. Explore our broader catalog of research compounds to support your lab's investigation into cellular signaling and tissue barrier models.
Frequently Asked Questions
What is the primary mechanism of action of KPV in research models?
Preclinical research demonstrates that KPV functions primarily by inhibiting the nuclear translocation of the NF-κB p65 subunit inside target cells. It enters cells via the PepT1 transporter and downregulates the transcription of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
How does KPV enter target cells during in vitro assays?
In vitro studies show that KPV is transported across cell membranes via PepT1 (SLC15A1), an active oligopeptide transporter highly expressed on intestinal epithelial cells, keratinocytes, and immune cells.
Does KPV cause skin pigmentation in animal models?
No. Unlike its parent molecule α-MSH, KPV lacks the N-terminal sequence required to bind and activate MC1R melanocortin receptors responsible for melanogenesis. It selectively mediates anti-inflammatory pathways without pigmentary activity.
How should reconstituted KPV be stored in the lab?
Once reconstituted in sterile water or PBS, KPV solutions should be divided into single-use aliquots and stored at -20°C or -80°C to prevent degradation. Working solutions kept at 4°C should be used within short experimental timeframes.
Why is endotoxin testing critical for KPV research?
Endotoxins (LPS) trigger strong NF-κB activation and inflammatory cytokine release in cell cultures and animal models. Using KPV with unverified endotoxin levels can mask or confound the compound's anti-inflammatory research outcomes.
What animal models are most commonly used to study KPV?
KPV is most frequently evaluated in rodent models of colonic inflammation induced by dextran sulfate sodium (DSS) or TNBS, as well as murine contact hypersensitivity and dermal wound-healing models.
What is the sequence and molecular weight of KPV?
KPV is a tripeptide with the chemical sequence Lysine-Proline-Valine (Lys-Pro-Val). It has a molecular weight of approximately 342.44 g/mol.
Where can lot-specific purity data for KPV be reviewed?
PX1 Research provides comprehensive third-party Certificates of Analysis (COAs) containing HPLC chromatograms and Mass Spectrometry reports for every batch, accessible via our COA portal.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.